4G Clinical Stock

We are equipped to answer the extreme cost and time pressures of clinical trials unlike anyone else.

Sign up today and learn more about 4G Clinical Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About 4G Clinical Stock

We reduce the time it takes to commercialize vital medications by delivering validated, easily extended RTSM capabilities faster than anyone in the world.

Funding History

January 2016$2.5M
October 2016$5.0M



Christine Hurley

Co-Founder & CTO

Ed Tourtellotte

Co-Founder & CEO

David Kelleher

Head of Engineering

Cedric Druck

EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: